▁arterial
ensitive
▁mutations
▁physici
▁distin
▁diabetes
cence
▁reas
rine
▁clinical
▁platelet
▁cultures
▁throm
▁follic
▁carb
▁Bec
▁inflamm
▁concentrations
ologic
▁stren
keletal
monary
▁accumulation
▁hepar
ogenous
▁HLA
▁atr
▁discus
oglyc
▁receptor
itamin
▁bone
▁fatty
sess
amic
arent
▁ventricular
olic
bility
▁biopsy
geal
▁assessment
▁screening
atid
▁prevalence
▁toxic
mental
▁infection
▁endothelial
▁distal
ocl
▁gangl
ration
▁numb
▁molecular
▁sensitivity
▁cervical
▁hepatitis
▁alcohol
▁preferen
▁clinically
▁abnormal
▁ovari
▁enhanced
erate
duce
tical
▁tas
ostic
▁increas
▁cate
incip
▁diffic
itro
tum
▁neonatal
▁mucosa
▁vitro
monstr
▁drugs
▁identif
▁mamm
loid
taining
▁statistically
▁survival
▁spontaneous
▁cere
▁pati
▁aortic
tic
▁transient
▁bac
▁bacter
treatment
▁potency
rents
▁predomin
▁gradi
genic
tions
▁progressive
ometr
▁transplantation
ronch
reast
▁urinary
▁pancreatic
requ
▁ovarian
▁elevation
▁suppression
▁reactions
onary
lymph
helial
▁decreased
▁describ
▁HIV
▁decreas
▁intravenous
▁vascular
▁infants
operative
▁atten
▁characterized
gative
phrine
oplas
▁melan
tinu
▁reac
odies
▁impaired
▁elic
▁labeling
▁provid
tle
▁ischem
▁graft
hemical
sive
▁epid
▁attrib
utaneous
▁tissue
atitis
▁lesions
ymp
▁IgM
▁ana
tensive
▁cerv
▁selective
sion
▁lymph
veolar
amine
▁somat
otor
omes
cine
dition
opathy
MG
pir
idne
▁artery
▁Patients
lastic
▁pregn
▁leuk
▁trials
crib
▁agon
tact
▁enhance
▁intra
ovascular
▁horm
▁interv
iotic
oplasm
tation
feren
▁excre
mitted
▁randomized
▁malignant
▁locus
▁proteins
▁arter
bly
ectom
▁rati
▁PT
▁reproduc
▁muscle
▁pregnancy
▁agonist
▁cyt
odynamic
▁chlor
▁hypertensive
▁physiological
ditions
namic
anding
▁chan
▁quantit
▁hypot
▁benz
▁bronch
ensity
▁biological
mong
▁rele
ologically
▁bloc
▁infarction
▁mechanisms
▁dysfunction
▁poten
MN
▁nec
MV
osal
entral
▁nerve
▁pharmac
▁bypass
otropic
duction
RH
▁sustained
▁ratios
stim
▁metabol
▁reduc
ocyte
tage
ingle
▁ethanol
tial
illary
▁lob
plantation
▁ventric
rox
GF
▁tumour
▁analys
asive
tent
rosis
▁surgery
▁severity
▁enhancement
▁pathway
ogra
vely
▁hypertension
▁investigated
▁vaccin
entical
▁depression
▁inhibitory
▁vitamin
itary
ociation
inic
▁chloride
▁comparable
▁determination
otype
associated
▁infusion
ethyl
▁mediated
▁acids
▁hypox
ilized
ilic
▁plac
idity
▁pancre
▁hypothe
ication
stolic
▁displ
athe
▁incidence
▁complic
▁exposure
▁impair
ociated
ignific
seud
rogen
▁carcinoma
▁metabolic
▁tissues
▁healthy
▁infar
tur
atients
sensitive
lyc
▁excretion
ocial
ameth
▁neph
▁gluc
▁hig
▁differen
▁postoperative
acet
▁examined
▁liver
mend
▁pituitary
▁skeletal
▁atrial
lusion
thal
▁correlated
▁peripheral
ergy
▁medial
▁doses
▁neutroph
BP
▁molec
ulatory
▁insulin
respon
inated
iciency
▁chol
▁ischemic
▁undergo
▁pneum
▁metast
▁diagnosis
tration
▁implic
tein
▁onset
▁involvement
▁spont
icient
ercise
▁regulation
▁adequ
▁antibodies
olution
ocar
tak
▁correspon
▁repl
trib
ascular
▁extre
▁Treatment
▁stimulation
▁stenosis
immun
▁specimens
▁feeding
tro
echn
▁stu
▁surf
▁establ
apse
▁techniqu
loro
oprote
gland
▁pig
▁detectable
▁adhe
▁laboratory
icin
▁clus
▁diabetic
lym
aneously
DH
quid
▁cathe
▁supple
▁concer
spective
▁valve
▁angi
▁stimul
ture
▁previ
ocytes
▁vag
▁monit
▁malign
▁analyses
▁serum
bral
▁perfusion
emic
▁underst
▁differentiation
olysis
pendent
radi
induced
▁wee
▁biop
rolog
▁pulmonary
aline
▁therapy
▁LV
ycin
arly
▁gland
▁preparations
▁quantitative
▁membrane
▁enti
ochemical
ploy
acr
▁glyc
▁necrosis
▁elevated
EA
▁behavi
▁remo
▁receptors
ectomy
osomal
▁hemodynamic
oic
▁beha
oprotein
▁experim
▁diet
▁iso
▁injur
▁proliferation
▁ey
▁chemotherapy
▁muc
positive
▁challen
ritis
dose
▁sour
▁vein
LV
orac
▁fibers
▁alterations
▁carcin
iable
▁surgical
ituitary
▁recur
yroid
▁cerebral
▁neurop
▁thromb
▁prol
▁achie
nec
natal
▁assay
▁uter
chol
▁hepat
▁perip
ucle
▁inhibit
▁reper
▁venous
▁shor
▁substance
rophob
▁catheter
▁hepatocytes
▁responsiveness
▁gastric
idation
▁haem
ialysis
▁infections
▁carbohyd
duc
▁myocardial
ses
oplasmic
mia
hyd
▁exogenous
entric
▁lesion
asal
▁examination
enic
▁IgG
▁recor
▁dyn
▁cardiac
▁BP
iatric
▁inhib
▁heparin
▁inhibition
▁muscles
▁scre
lux
DNA
▁stimuli
yro
ctive
ficial
▁synthesis
▁systolic
▁tumor
ilateral
▁tox
▁aor
▁ischemia
dominal
osin
ulin
ximal
itant
▁hypo
▁oste
▁tes
kers
▁symptoms
▁coronary
aired
▁localized
▁abnormalities
iol
itone
▁intake
▁sten
anol
▁syndrome
atment
angl
▁activated
▁preparation
▁Addition
▁disorders
▁excl
sor
erative
sized
▁restric
dle
▁stimulate
▁glycoprotein
urther
▁prevented
▁metabolism
▁stab
▁complications
▁AMP
omal
ropriate
▁neon
oscop
rous
▁tumors
▁toxicity
▁phenotype
▁LDL
eration
tin
▁HP
ocaine
▁lipoprotein
▁molecule
▁peripher
alian
▁respon
▁decline
roup
▁cardi
▁opi
▁requi
▁rhy
ocytic
▁specificity
mg
▁ultras
aemia
▁parame
▁progn
▁diagnostic
▁shif
▁inflammatory
▁arteries
▁pH
ygen
arb
duced
▁synthe
▁exis
armac
▁paras
▁TGF
▁hormone
▁glut
ortic
▁examin
▁experi
▁measuring
▁secretion
lec
▁reperfusion
▁infected
▁sulf
▁deter
▁deficiency
▁antic
▁oral
▁symptom
▁treatments
▁sampl
onate
owever
▁assays
▁uptake
▁prolonged
▁AI
▁lipid
sia
▁thyroid
echan
toc
▁dose
▁dex
▁phy
▁olig
sy
ocyt
▁mg
ateral
ults
▁mortality
kely
▁morphology
tif
eric
▁injections
▁hep
▁predominantly
▁occurring
▁hepatic
tors
▁mono
▁predic
▁genetic
▁immun
▁ure
ially
hest
▁urine
▁glomerular
▁Tran
▁spinal
erated
entif
▁tiss
▁diseases
▁structural
▁cann
▁smo
▁cardiovascular
▁cereb
gth
plic
▁amin
ayed
mentation
▁chronic
pite
ergic
▁genes
▁irradi
otyp
▁efficacy
▁tolerance
trol
arge
tained
▁dys
▁immune
imens
▁maternal
▁preval
otherapy
eled
sych
▁embry
tive
▁aden
osom
lood
mented
▁systemic
▁mild
▁bladder
▁saline
leu
BV
▁adults
▁spon
RP
adder
▁fetal
▁estrogen
▁dietary
▁glucose
sis
▁intraven
▁renal
▁injected
▁inhibitors
▁therapeutic
▁heterogene
▁antib
▁nucleus
▁oxygen
▁fiber
▁transi
▁PD
urine
▁findings
▁moderate
▁glomer
fusion
▁evoked
mature
▁acute
orrh
▁kidney
▁heal
